Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | -5.14% | -7.52% | +10.93% |
Financials (USD)
Sales 2024 * | 24.79M | Sales 2025 * | 71.17M | Capitalization | 363M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -44M | EV / Sales 2024 * | 14.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.1 x |
P/E ratio 2024 * |
-5.65
x | P/E ratio 2025 * |
-9.76
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.08% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | -5.14% | ||
1 week | -7.52% | ||
Current month | -4.58% | ||
1 month | -15.06% | ||
3 months | +57.36% | ||
6 months | +111.46% | ||
Current year | +10.93% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 32 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 8.12 | -5.14% | 108,791 |
24-06-13 | 8.56 | -0.23% | 81,013 |
24-06-12 | 8.58 | -3.92% | 179,846 |
24-06-11 | 8.93 | +4.32% | 185,414 |
24-06-10 | 8.56 | +4.65% | 202,087 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.93% | 363M | |
+50.70% | 795B | |
+41.96% | 627B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.68% | 160B |
- Stock Market
- Equities
- VRCA Stock